옵션 체인은 다양한 행사가격과 만기일에 대한 Kiromic BioPharma Inc Ordinary Shares의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Kiromic BioPharma Inc Ordinary Shares에 대한 시장 심리를 평가합니다..

Kiromic BioPharma Inc Ordinary Shares (OTC:KRBP) 주식, 옵션 체인

Kiromic BioPharma

Major Institutional Interest

Biotech

News

Legal

General

KRBP

사기 혐의로 51개월 징역형 선고 및 610만 달러 배상 명령받은 남성 라스베이거스에 거주하는 55세의 미칼라이 콘틸라이(Mykalai Kontilai)는 목요일에 장기 사기 계획에 연루된 혐의로 징역 51개월과 배상금으로 610만 달러를 지불하라는 선고를 받았다. 이전에 마이클 콘틸레(Michael Contile)로 알려진 콘틸라이는 콜렉터스 카페(Collector&#39;s Café)라고도 알려진 그의 회사인 콜렉터스 커피(Collector&#39;s Coffee Inc.)를 통해 투자 사기를 주도했다.

주간 금융 범죄: 콘틸라이에 51개월 형 선고, 키로믹은 중요 정보 미공개로 기소

Kiromic BioPharma Inc Ordinary Shares

KIROMIC BIOPHARMA INC by Kiromic BioPharma, Inc.

Kiromic BioPharma Inc

WIIM

NAGE

Niagen Bioscience shares are trading higher after Roth Capital maintained its Buy rating on the stock and raised the price target from $10 to $23.

Bank of America Securities analyst Shaun C. Kelley reiterated the Neutral rating on Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) on Friday, with a <a href="https://www.benzinga.com/quote/MTN/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast of $175.</a>
The firm reported third-quarter revenue of $1.29 billion, narrowly missing estimates of $1.3 billion, according to&nbsp;<a target="_blank" href="http://pro.benzinga.com/" rel="noreferrer noopener">Benzinga Pro</a>.
Vail Resorts reported third-quarter earnings of $10.54 per share, <a href="https://www.benzinga.com/markets/earnings/25/06/45804290/vail-resorts-stock-slides-on-q3-earnings-company-targets-100-million-in-annualized-cost-efficiencies">beating estimates of $10.12 per share.</a>
Kelley notes that it&#8217;s still early to assess the full impact of Vail Resorts&#8217; new strategy, suggesting FY27 may offer a clearer picture than FY26 due to the time needed for pricing adjustments and filling the CMO role.
Also Read:<a target="_blank" href="https://www.benzinga.com/25/05/45655410/vail-resorts-ceo-shake-up-spurs-analyst-action-jp-morgan-upgrades-bank-of-america-lifts-price-forecast-amid-growth-rebound-hopes" rel="noreferrer noopener"> Vail Resorts CEO Shake-Up Spurs Hopes Of Growth Rebound</a>
On capital allocation, Kelley points out that the dividend appears stable for now. Future growth depends on significantly higher cash flows. No major shifts in M&amp;A plans are expected in the near term.
As of May 27, Vail Resorts reported a 1% year-over-year decline in pass units, while total dollars rose 2%.
The company had raised prices by 7% across its pass offerings, and the gap suggests a customer shift toward lower-priced products. Management highlighted healthy demand for day passes and noted no significant downgrade behavior, with customer migration trends holding steady compared to the last three years. Vail anticipates pass performance to remain stable through the rest of the season.
For FY26 EBITDA, Kelley highlights that key drivers include $33 million in net resource efficiency gains, $9 million from cycling past one-time CEO transition costs, $7 million from favorable foreign exchange, and approximately $10 million from improvements at Park City—contributing to the company&#8217;s $900 million EBITDA estimate for FY26.
Price Action: MTN shares are trading lower by 3.89% to $148.97 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45820057/chewys-loyalty-engine-1b-pharmacy-business-have-jpmorgan-staying-bullish-before-q1" target="_blank" rel="noreferrer noopener">Chewy&#8217;s Loyalty Engine, $1B Pharmacy Business Have JPMorgan Staying Bullish Before Q1</a></li>
</ul>
Image: Shutterstock

Equities

Markets

Analyst Ratings

Trading Ideas

Vail Resorts' Near-Term Strategy Centers On Marketing, AI, And Stable Dividend: Analyst

Hut 8 shares are trading higher after Roth Capital initiated its coverage on the stock with a Buy rating and announced a price target of $25.

BBCP

Concrete Pumping shares are trading lower after the company reported worse-than-expected Q2 financial results.

Needham analyst Joseph Stringer maintains Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) with a Buy and maintains $28 price target.

Price Target

PHAT

Needham Maintains Buy on Phathom Pharmaceuticals, Maintains $28 Price Target

Bank of America Securities analyst Mihir Bhatia reiterated the Underperform rating on SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) on Friday, <a href="https://www.benzinga.com/quote/SOFI/analyst-ratings" target="_blank" rel="noreferrer noopener">with a price forecast of $13</a>.
At the 45th Annual William Blair Growth Stock <a href="https://www.williamblair.com/News/William-Blair-Hosts-45th-Annual-Growth-Stock-Conference" target="_blank" rel="noreferrer noopener">Conference </a>on Wednesday, SoFi CFO Chris Lapointe showcased the company's expanding reach. It now boasts approximately 11 million members <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45802964/sofi-technologies-stock-climbs-as-company-touts-strong-growth-at-investor-conference" target="_blank" rel="noreferrer noopener">and over 15 million products.</a>
The analyst notes that SoFi&#8217;s Financial Services products—Money, Relay, and Invest—are broad-entry tools that attract users to its platform.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45112668/sofi-could-become-american-express-of-fintech-analyst" rel="noreferrer noopener">SoFi Could Become &#8216;American Express Of Fintech&#8217;: Analyst</a>
Once users are in the system, the company leverages its Financial Services Productivity Loop to cross-sell offerings, including those in the Lending segment.
Bhatia also highlights the Loan Platform as a major growth driver over the past year.
SoFi originates loans in a capital-light way and earns strong income from the product.
In the first quarter FY25, the company originated $1.6 billion in third-party loans and expects continued growth, especially if credit standards ease. With 84% year-over-year growth in the quarter, the product is gaining momentum and is poised to become a key revenue contributor.
The analyst points out that SoFi sees its Invest product as a major driver of Financial Services growth in 2025.
Management views it as potentially the next standout offering—comparable to Money, which SoFi considers its benchmark product.
The company has already added features like a robo-advisor and funds, and is now shifting focus to monetization and asset expansion.
Bhatia writes that these efforts are expected to support both revenue and contribution profit growth in 2025 and beyond.
Price Action: SOFI shares are trading higher by 2.01% to $13.98&nbsp;at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45820057/chewys-loyalty-engine-1b-pharmacy-business-have-jpmorgan-staying-bullish-before-q1" target="_blank" rel="noreferrer noopener">Chewy&#8217;s Loyalty Engine, $1B Pharmacy Business Have JPMorgan Staying Bullish Before Q1</a></li>
</ul>
Image: Shutterstock

SOFI

SoFi Loan Boom Impresses But Bank Of America Sticks To 'Underperform'

BYRN

Byrna Technologies shares are trading higher after B. Riley Securities reiterated its Buy rating and raises the price target on the stock from $38 to $39.

Toro shares are trading lower after multiple firms lowered their respective price targets on the stock.

<a href="https://trumpstruth.org/statuses/31388" title="https://trumpstruth.org/statuses/31388">https://trumpstruth.org/statuses/31388</a>

Macro Economic Events

Politics

Global

Economics

Donald Trump Posts On Truth Social "I am pleased to announce that Secretary of the Treasury Scott Bessent, Secretary of Commerce Howard Lutnick, and United States Trade Representative, Ambassador Jamieson Greer, will be meeting in London on Monday, June 9, 2025, with Representatives of China, with reference to the Trade Deal. The meeting should go very well..."

<h2 class="wp-block-heading">Key Takeaways:</h2>
<ul class="wp-block-list">
<li>L3Harris Technologies Inc. (NYSE: <a href="https://www.benzinga.com/quote/LHX">LHX</a>) trades at lower valuation multiples despite delivering steady contract growth and strong positioning in modern defense segments.</li>
</ul>
<ul class="wp-block-list">
<li>Behind the scenes, LHX is building strength in areas the market increasingly cares about: space tech, secure communications, and classified defense systems.</li>
</ul>
<ul class="wp-block-list">
<li>With a growing backlog and steady cash flow, it's the kind of stock that quietly builds momentum, until the market eventually catches up.</li>
</ul>
<h2 class="wp-block-heading">A Quiet Climb in a Defensive Sector</h2>
Defense stocks don't always make headlines, until something goes wrong. Over the past year L3Harris Technologies Inc. has been doing what a lot of investors want right now, which is staying steady, delivering results, and building long-term contracts.&nbsp;
As of early June, shares of L3Harris were trading at approximately $242, down around 3.2% year-over-year. That's a modest decline, especially when you consider the broader market chop and the fact that Lockheed Martin (NYSE: <a href="https://www.benzinga.com/quote/LMT">LMT</a>), a bigger defense peer, gained less than 4% over the same period. From a valuation standpoint, L3Harris is also smaller than both LMT and RTX (NYSE: <a href="https://www.benzinga.com/quote/RTX">RTX</a>), with a market cap of roughly $44.87 billion compared to RTX's $185.70 billion.
That size gap might explain why the market still prices LHX at a discount, but the fundamentals tell a different story. The company continues to generate solid free cash flow, expand its presence in next-gen battlefield technologies, and build out capabilities in space and missile defense.&nbsp;
For investors looking beyond the headlines, the disconnect between what LHX is doing and what it's currently worth might not last forever.
<h2 class="wp-block-heading">Valuation Breakdown: Underrated by the Numbers</h2>
L3Harris doesn't necessarily trade like a market favorite currently, but the numbers suggest that it deserves a closer look. Right now, it has a P/E ratio of 28.71, which lands between Lockheed Martin at 20.60 and RTX Corp. at 40.78. Not the cheapest, not the most expensive, just sitting quietly in the middle.
Its dividend yield comes in at 1.98%, just slightly ahead of RTX, and a bit behind LMT's 2.76%. Again, nothing flashy, but it adds to the picture of a company that's stable and returning value to shareholders.
But behind the scenes, LHX has made progress. It focused its operations, kept cash flow steady, and moved deeper into areas like electronic warfare, space systems, and next-gen battlefield tech. Investors may still be cautious after past M&amp;A deals or slower revenue growth, but the core business is holding up well.
If the company continues to deliver, the market may have to reprice that story. For now, the stock still looks like it's being overlooked.
<h2 class="wp-block-heading">Where The Growth is Coming From</h2>
L3Harris isn't putting all its weight behind one big program. Instead, it's building momentum across a mix of high-impact defense segments that offer more than just short-term wins.
<h3 class="wp-block-heading">Space and Airborne Systems: A Quiet Momentum</h3>
These systems are one of its fastest-growing areas. The company develops sensors, payloads, and support systems for missions ranging from ISR and missile tracking to weather and navigation. It also works on the ground systems that power satellite communication and defense, plus advanced avionics and electronic warfare tools.
<h3 class="wp-block-heading">Tactical Comms and Classified Wins</h3>
Tactical Communications is another key element. LHX delivers <a href="https://www.l3harris.com/all-capabilities/integrated-tactical-communication-systems">integrated systems</a> that help military teams stay connected in the field that's secure, fast, and built for high-pressure environments. Then there's the classified and cyber defense work, much of which doesn't show up in headlines but continues to grow in priority and funding.
In Q1 2025, L3 Harris reported <a href="https://www.reuters.com/business/aerospace-defense/l3harris-forecasts-upbeat-annual-sales-strong-defense-demand-2025-01-30/">$5.52 billion in revenue</a> and raised its cost-saving target to $1.2 billion for the year. Compared to Lockheed Martin's heavier reliance on the F-35 or RTX's commercial aviation exposure, LHX's diversified defense-first model looks well positioned for what's ahead.
<h2 class="wp-block-heading">Short-Term Catalysts: What Could Move the Stock This Year</h2>
L3Harris might not make the loudest headlines, but a few developments could give the stock real momentum this year. First, the <a href="https://comptroller.defense.gov/Budget-Materials/Budget2025/">FY2025 defense budget</a> is leaning heavily into modernization and readiness, two areas where L3Harris already has a strong presence. More funding means more room for the kind of advanced tech the company is building within modern defense segments.
That momentum is already evident when looking at contracts. L3Harris recently picked up a <a href="https://www.l3harris.com/newsroom/press-release/2025/03/us-space-force-selects-l3harris-continue-modernization-space-domain">$90 million deal</a> with the U.S. Space Force to improve space domain awareness, essentially helping the military better detect and track objects in orbit. Additionally, the company landed close to <a href="https://www.ctol.digital/news/l3harris-lands-300-million-us-army-contract-next-gen-battlefield-radios/">$300 million</a> from the Army to deliver mission-critical comms gear as part of the HMS program. Both deals reinforce its role in next-gen defense infrastructure.
By contrast, some of its peers are navigating challenges. Lockheed Martin is still wrestling with F-35 cost issues, and RTX remains tied to <a href="https://www.rtx.com/news/news-center/2025/04/22/rtx-reports-q1-2025-results">commercial aerospace</a>, which doesn't have the same insulation from market volatility.
In a defense-heavy environment, LHX's steady contract flow and focus on core military needs could give it a clearer path forward.
<h2 class="wp-block-heading">Long-Term Upside: Space, Security, and Modern Warfare</h2>
L3Harris is busy positioning itself for the future of defense. Instead of relying on one big program, it's spreading its bets across some of the most important areas in modern warfare, space systems, secure communications, and <a href="https://www.l3harris.com/newsroom/press-release/2025/02/l3harris-and-shield-ai-team-breakthrough-autonomy">battlefield technologies that integrate AI</a>.
<h3 class="wp-block-heading">Tracking Global Defense Priorities</h3>
Its strategy lines up with broader U.S. and NATO priorities around modernization and readiness. L3Harris's focus on modern defense tools lines up with the broader defense shift toward modernization, especially in areas getting more funding attention in recent U.S. and NATO strategy updates.
Leadership is also staying confident. In its most recent earnings report, L3Harris reaffirmed its full-year outlook and highlighted its long-term investments in high-margin areas. And because the company generates strong free cash flow and continues to reinvest in core segments, it has the flexibility to keep building for what's next.
In a sector where demand is often tied to cycles and political shifts, LHX's focus on foundational technologies, backed by steady government contracts, gives it a rare kind of staying power.
<h2 class="wp-block-heading">Risks and Headwinds</h2>
L3Harris has a lot going for it, but it's not without challenges. The Aerojet Rocketdyne acquisition is still being absorbed, and like with any big deal, there's always a chance the integration takes longer or costs more than expected.
There's also some margin pressure to watch. Inflation, wage costs, and supply chain friction have been hitting defense contractors across the board, and L3Harris isn't immune. Recent revenue growth has been solid, but not exactly explosive, so any slowdown in contract wins could take the shine off in the short term.
Then there's the bigger picture: L3Harris is closely tied to U.S. and allied defense budgets. If priorities shift or possession gets delayed, something that's been happening more often, some of that steady momentum could stall. None of this breaks the long-term case, but it's worth keeping in mind if you're expecting a quick payoff.
<h2 class="wp-block-heading">Is the Market Mispricing LHX?</h2>
L3Harris is sitting on a strong foundation, playing in the right growth areas like space systems, secure comms, and cyber, and is still trading at a discount to peers.
Investors may be overlooking how well-positioned LHX really is. While others lean heavily on one or two flagship programs, L3Harris is quietly building a diversified, future-ready defense portfolio that lines up with where global spending is heading.
If margins stay healthy and contract wins keep coming in, the market may have to rethink how it values this stock. Over the next 12 to 18 months, there's real potential for a rerating.
Featured Image is AI generated

Long Ideas

SPACE

Travel

Opinion

Signals

Why L3Harris Might Be The Most Undervalued Stock in the Defense Sector

Fartcoin (CRYPTO: FARTCOIN) has defied the broader market downturn with <a href="https://www.benzinga.com/money/fartcoin-price-prediction#:~:text=Maximum%20Prediction%3A%20%242.26,increase%20from%20its%20current%20value.">a 4% gain today</a>, outperforming major meme coins like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>).
What Happened: Prominent trader Unipcs <a href="https://x.com/theunipcs/status/1930637347474809194">revealed</a> an unrealized PnL of $4.49 million on his Fartcoin holdings, down $1.17 million in three days and $2.64 million in three weeks. 
Despite the sharp drawdown, Unipcs remains committed, arguing that Fartcoin is oversold and bearish sentiment is overstretched.
The trader highlighted the emotional and financial volatility behind big PnLs and emphasized the importance of conviction in sticking to a thesis despite drawdowns.
He also <a href="https://x.com/theunipcs/status/1930729013347025323">pointed</a> out the timing of Coinbase's listing announcement, which he believes could be a catalyst, with Robinhood possibly next in line.
Kadense Pengu noted Fartcoin has retraced 50% from local highs after an 8x rally, pulling back to $0.93, which could serve as a key retest level and buying opportunity. 
The recent Coinbase listing marks a major milestone, with more CEX listings likely, increasing accessibility for retail investors and amplifying the memetic appeal.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">After explosive 8x move from the lows, $fartcoin has pulled back ~50% from local high Coinbase listing news yesterday. Likely other major CEX to follow suit. Onramps growing for normies to participate and be in on the &#39;joke&#39; Pullback to $0.93 as retest may be a good entry <a href="https://t.co/W2AfRF9Joy">pic.twitter.com/W2AfRF9Joy</a>
&mdash; Kadense Pengu°&#x2757;&#xFE0F;&#x2757;&#xFE0F;&#x2757;&#xFE0F; (@iamkadense) <a href="https://twitter.com/iamkadense/status/1931034925613875502?ref_src=twsrc%5Etfw">June 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Altcoin Sherpa <a href="https://x.com/AltcoinSherpa/status/1930739419524563199">said</a> the outperformance is undeniable and <a href="https://x.com/AltcoinSherpa/status/1930717550348054848">confirmed</a> opening a long position. 
More Crypto Online <a href="https://x.com/Morecryptoonl/status/1930984136421814569">predicts</a> a potential next leg up is in play, targeting the $1.10–$1.428 range as the first key resistance zone to watch.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45777180/fartcoin-slides-10-in-a-day-what-is-going-on">Fartcoin Slides 10% In A Day: What Is Going On?</a>
Why It Matters: Fartcoin's Coinbase roadmap listing has added a new layer of legitimacy and investor attention. 
The exchange said the move is part of its effort to boost transparency by sharing assets under consideration. 
The news triggered a 52.6% surge in 24-hour trading volume.
Coinglass data shows open interest in the meme coin also saw a sudden spike (+2.2%) after the news. Derivatives trading volume in the meme coin expanded by 31.4%.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/06/45714033/fartcoin-outgains-dogecoin-shiba-inu-sunday-night-whats-going-on">Fartcoin Outgains Dogecoin, Shiba Inu Sunday Night—What&#8217;s Going On?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$SHIB

Fartcoin Jumps 4% While Dogecoin, Shiba Inu Fall — 'Outperformance Is Undeniable,' Says Trader

ServiceTitan, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) reported mixed first-quarter <a href="https://www.benzinga.com/quote/TTAN/earnings">results on Thursday</a>.
ServiceTitan posted adjusted earnings of 18 cents per share, beating market estimates of 12 cents per share. The company's quarterly sales came in at $215.69 million versus expectations of $208.69 million.
The company raised its FY2026 sales guidance from $895.00 million-$905.00 million to $910.00 million-$920.00 million.
&#8220;The ROI we deliver to our customers continues to be our greatest advantage,&#8221; said Vahe Kuzoyan, Co-Founder and President, &#8220;We&#8217;re building a series of stacking S-curves to put ourselves in a position to deliver transformative customer outcomes, and each of our four primary areas of focus this year are off to a strong start.&#8221;
ServiceTitan shares dipped 7.7% to trade at $105.68 on Friday.
These analysts made changes to their price targets on ServiceTitan following earnings announcement.
<ul class="wp-block-list">
<li>Morgan Stanley analyst Josh Baer maintained ServiceTitan with an Equal-Weight rating and raised the price target from $107 to $109.</li>
<li>Loop Capital analyst Yun Kim maintained the stock with a Hold and raised the price target from $90 to $100.</li>
<li>Needham analyst Scott Berg reiterated ServiceTitan with a Buy and maintained a $140 price target.</li>
</ul>
Considering buying TTAN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="602" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06142113/image-108-1024x602.png" alt="" class="wp-image-941698" style="width:624px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06142113/image-108-1024x602.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06142113/image-108-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06142113/image-108-768x451.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06142113/image-108.png 1140w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45813240/top-2-energy-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Energy Stocks That May Fall Off A Cliff In Q2</a></li>
</ul>
Photo via Shutterstock

Earnings

TTAN

These Analysts Increase Their Forecasts On ServiceTitan After Q1 Results

UBS analyst David Vogt maintains Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Neutral and raises the price target from $73 to $78.

CIEN

UBS Maintains Neutral on Ciena, Raises Price Target to $78

CYCU

Cycurion Announces Continued Listing And Trading Of Shares And Warrants On NASDAQ

Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NASDAQ">ABL</a>), a leader in the alternative asset management space, today announced that its Board of Directors has authorized a new $20 million share repurchase program, effective June 5, 2025 for over a period of up to 18 months, as well as recent Form 4 and other employee share purchases totaling over $2 million.

Buybacks

Abacus Global Management Announces New $20M Share Repurchase Program

Brown-Forman Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) reported weaker-than-expected fourth-quarter <a href="https://www.benzinga.com/quote/BF.B/earnings">fiscal 2025 results on Thursday.</a>
The spirits maker posted quarterly net sales of $894 million, down 7% from a year ago and 3% lower on an organic basis. The figure missed analyst expectations of $967.39 million. Diluted earnings per share fell 45% to 31 cents, missing the consensus estimate of 34 cents.
Brown-Forman expects a tough operating landscape in fiscal 2026 amid macroeconomic uncertainty, potential new tariffs, and softer non-branded barrel sales. The company projects low-single-digit declines in both organic net sales and operating income, with a tax rate between 21% and 23%. Capital spending is forecast between $125 million and $135 million.
BF.B shares gained 3.1% to trade at $28.08 on Friday.
These analysts made changes to their price targets on Brown-Forman following earnings announcement.
<ul class="wp-block-list">
<li>JP Morgan analyst Andrea Teixeira maintained Brown-Forman with an Underweight rating and lowered the price target from $34 to $28.</li>
<li>Evercore ISI Group analyst Robert Ottenstein maintained the stock with an In-Line rating and lowered the price target from $38 to $30.</li>
<li>RBC Capital analyst Nik Modi maintained Brown-Forman with a Sector Perform and lowered the price target from $44 to $30.</li>
<li>Morgan Stanley analyst Eric Serotta maintained the stock with an Underweight rating and cut the price target from $32 to $29.</li>
<li>Citigroup analyst Filippo Falorni maintained Brown-Forman with a Neutral and lowered the price target from $35 to $28.</li>
</ul>
Considering buying BF.B stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="609" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06141025/image-107-1024x609.png" alt="" class="wp-image-941689" style="width:633px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06141025/image-107-1024x609.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06141025/image-107-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06141025/image-107-768x457.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06141025/image-107.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45813240/top-2-energy-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Energy Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

Brown-Forman Analysts Slash Their Forecasts After Weak Q4 Results

Scotiabank analyst Nick Altmann maintains GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) with a Sector Outperform and lowers the price target from $80 to $67.

GTLB

Scotiabank Maintains Sector Outperform on GitLab, Lowers Price Target to $67

Vail Resorts Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) reported mixed financial results for the third quarter on <a href="https://www.benzinga.com/quote/mtn/earnings">Thursday after the bell</a>.
Vail Resorts reported third-quarter revenue of $1.29 billion, narrowly missing estimates of $1.3 billion, according to Benzinga Pro. The company reported third-quarter earnings of $10.54 per share, beating estimates of $10.12 per share.
"Results in the quarter reflect the stability provided by our season pass program as Resort net revenue, excluding Crans-Montana, remained consistent with the prior year even as visitation declined 7%," said Rob Katz, CEO of Vail Resorts.
The company expects fiscal 2025 net income attributable to Vail Resorts to be between $264 million and $298 million, and Resort Reported EBITDA for fiscal 2025 to be between $831 million and $851 million.
Vail Resorts shares dipped 3.9% to trade at $149.00 on Friday.
These analysts made changes to their price targets on Vail Resorts following earnings announcement.
<ul class="wp-block-list">
<li>Truist Securities analyst Patrick Scholes maintained Vail Resorts with a Buy and lowered the price target from $247 to $244.</li>
<li>Morgan Stanley analyst Megan Alexander maintained the stock with an Equal-Weight rating and cut the price target from $152 to $146.</li>
<li>Mizuho analyst Ben Chaiken maintained Vail Resorts with an Outperform rating and raised the price target from $215 to $216.</li>
</ul>
Considering buying MTN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/MTN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="573" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06140303/image-106-1024x573.png" alt="" class="wp-image-941678" style="width:628px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06140303/image-106-1024x573.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06140303/image-106-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06140303/image-106-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06140303/image-106.png 1123w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45813240/top-2-energy-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Energy Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

These Analysts Revise Their Forecasts On Vail Resorts After Q3 Results

Scotiabank analyst Ovais Habib maintains Orla Mining (TSX:<a class="ticker" href="https://www.benzinga.com/stock/OLA#TSX">OLA</a>) with a Sector Outperform and raises the price target from C$15.5 to C$16.

TSX:OLA

Scotiabank Maintains Sector Outperform on Orla Mining, Raises Price Target to C$16

Deep-pocketed investors have adopted a bullish approach towards Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Mastercard. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $255,135, and 4 are calls, amounting to $112,675.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $530.0 to $660.0 for Mastercard over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Mastercard options trades today is 264.57 with a total volume of 1,113.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Mastercard's big money trades within a strike price range of $530.0 to $660.0 over the last 30 days.
<h3>Mastercard 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749232966_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/13/25</td>
<td>$2.88</td>
<td>$2.73</td>
<td>$2.76</td>
<td>$580.00</td>
<td>$114.1K</td>
<td align="right">49</td>
<td align="right">442</td>
</tr>
<tr>
<td>MA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/13/25</td>
<td>$1.74</td>
<td>$1.56</td>
<td>$1.6</td>
<td>$575.00</td>
<td>$55.3K</td>
<td align="right">789</td>
<td align="right">342</td>
</tr>
<tr>
<td>MA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$25.1</td>
<td>$24.6</td>
<td>$24.96</td>
<td>$600.00</td>
<td>$49.9K</td>
<td align="right">98</td>
<td align="right">40</td>
</tr>
<tr>
<td>MA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$2.25</td>
<td>$2.15</td>
<td>$2.25</td>
<td>$530.00</td>
<td>$35.7K</td>
<td align="right">501</td>
<td align="right">180</td>
</tr>
<tr>
<td>MA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$18.0</td>
<td>$17.45</td>
<td>$17.75</td>
<td>$575.00</td>
<td>$30.1K</td>
<td align="right">340</td>
<td align="right">25</td>
</tr>
</tbody>
</table>

<h3>About Mastercard</h3>
Mastercard is the second-largest payment processor in the world, having processed close to $10 trillion in volume during 2024. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.
Having examined the options trading patterns of Mastercard, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Mastercard Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 746,651, the MA's price is up by 0.37%, now at $587.59. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 54 days.</li>
</ul>
<h3>Expert Opinions on Mastercard</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $656.25.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Mastercard, which currently sits at a price target of $660. 
&#x2A; An analyst from Jefferies persists with their Buy rating on Mastercard, maintaining a target price of $655. 
&#x2A; An analyst from Truist Securities downgraded its action to Buy with a price target of $640. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Mastercard, which currently sits at a price target of $670. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Mastercard with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Looking At Mastercard's Recent Unusual Options Activity

Press Releases

Kiromic BioPharma Provides Update on Part 1 of the Deltacel-01 Trial

Kiromic BioPharma's Deltacel Receives FDA Fast Track Designation

Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation

Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial

Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial

Kiromic BioPharma Reports Favorable Ongoing Clinical Results From Fourth and Sixth Patients Enrolled in Deltacel-01

Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation

Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01

Kiromic BioPharma Reports Tumor Volume Decrease in Two Patients Enrolled in Deltacel-01

Kiromic BioPharma Reports Patient 4 in Deltacel-01 Clinical Trial Reaches 10-Month Progression-Free Survival

Comments

Kiromic BioPharma Inc Ordinary Shares

Kiromic BioPharma Inc Ordinary Shares (KRBP) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌